These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6495258)

  • 1. Prothrombin evaluation as obtained by kinetics studies of antigen-antibody reaction in a laser nephelometer.
    Girolami A; Sticchi A; Melizzi R; Saggin L; Ruzza G
    Thromb Haemost; 1984 Aug; 52(1):15-8. PubMed ID: 6495258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of laser nephelometer in the study of abnormal clotting factors: characterization of two abnormal antithrombins (AT III Padua and AT III Padua2).
    Girolami A; Ruzza G; Saggin L; Sticchi A; Melizzi R
    Am J Clin Pathol; 1984 Mar; 81(3):323-8. PubMed ID: 6702724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser nephelometer evaluation of factor IX.
    Ruzza G; Lazzaro AR; Viero ML; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):843-9. PubMed ID: 1713891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin antigen evaluation by means of laser nephelometry in health and disease.
    Girolami A; Saggin L; Ruffato G; Sticchi A; Capellato G
    Am J Clin Pathol; 1982 Nov; 78(5):773-6. PubMed ID: 7137121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between normal antithrombin III and antithrombin III Padua as determined by laser nephelometry.
    Girolami A; Saggin L; Sticchi A; Ruffato G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):895-900. PubMed ID: 6187642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosis.
    Girolami A; Antico S; Pengo V; Ruffato G; Callegari F; Cappellato M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):920-7. PubMed ID: 2419222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times.
    Zhao Y; Rumold R; Zhu M; Zhou D; Ahmed AE; Le DT; Hahn BH; Woods VL; Chen PP
    Arthritis Rheum; 1999 Oct; 42(10):2132-8. PubMed ID: 10524684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias.
    Girolami A; Patrassi G; Toffanin F; Saggin L
    Am J Clin Pathol; 1980 Jul; 74(1):83-7. PubMed ID: 7395819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidin-biotin ELISA for measurement of prothrombin in human plasma.
    Koldas M; Uras F
    Thromb Res; 2001 May; 102(3):221-7. PubMed ID: 11369415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio.
    van den Besselaar AM; Houbouyan-Reveillard LL; Aillaud MF; Denson KW; Droullé C; Johnston M; Kitchen S; Lindahl TL; Marren M; Martinuzzo ME; Tripodi A; Vergnes C
    Thromb Haemost; 1999 Nov; 82(5):1451-5. PubMed ID: 10595637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laser nephelometry for the quantitative determination of the interaction between peanut lectins and asialoglycoproteins].
    Caron M; Ohanessian J; Faure A
    C R Seances Acad Sci III; 1982 Jan; 294(4):203-6. PubMed ID: 6805862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
    Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
    Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of prothrombin bound in immune complexes results in high thrombin enzymatic activity.
    Pajdak W; Radwan J; Guzik TJ
    J Physiol Pharmacol; 2004 Jun; 55(2):477-84. PubMed ID: 15213367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.